During every cell cycle, human cells must accurately and efficiently replicate over six billion base pairs of DNA. Replicating a genome of this size that is packed into a very small nucleus constitutes an enormous logistical, spatial and energetic challenge. Furthermore, there are numerous impediments encountered by DNA replication forks that block their progression, including DNA damage, the transcription machinery, RNA-DNA hybrids and secondary DNA structures 1 . Unsurprisingly, cells have robust replication stress response mechanisms to ensure the entire genome is accurately replicated once every cell cycle.
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The kinase ataxia telangiectasia and Rad3-related (ATR) orchestrates multiple branches of the replication stress response. It is essential for cell viability, and, emphasizing its importance, ATR-deficient embryos have shattered chromosomes 2, 3 . Moreover, hypo morphic alleles of ATR cause the developmental disorder Seckel syndrome, which is characterized by primordial dwarfism, microcephaly, craniofacial abnormalities and intellectual disability 4 . ATR is a phosphoinositide 3-kinase-related protein kinase 5, 6 . It shares sequence and functional homology with two other DNA damage response kinases, ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase (DNA-PK). Both ATM and DNA-PK respond primarily to DNA double-strand breaks (DSBs), and in contrast to ATR, neither is essential for cell survival 7 . This difference highlights the essential role of the replication stress response in ensuring faithful duplication of a challenging genome. Although ATR has other functions, including during DSB repair 8 , inter-strand crosslink repair 8 and meiosis 9 , as well as at telomeres 10 and in response to mechanical and osmotic stresses 11 , in this Review we focus on the function of ATR in the replication stress response. We begin with an overview of how cells detect replication stress and activ ate the checkpoint, and later discuss the mechanisms by which the ATR signalling pathway helps replication forks overcome replication stress.
Mechanisms of ATR activation ATR responds to many types of genotoxic stress, including stress induced by ultraviolet radiation, DNA polymerase inhibitors, deoxyribonucleoside triphosphate (dNTP) depletion, topoisomerase poisons, basealkylating agents and DNA crosslinkers 12 . A common theme linking these stressors is that they stall or slow DNA polymerases. Numerous factors work together to form the basic components to recruit and activate ATR at stressed replication forks.
Topoisomerase
An enzyme that relieves torsional stress caused by DNA supercoiling during replication or transcription.
SOS DNA damage response
A bacterial DNA damage response that arrests the cell cycle and induces error-prone DNA repair.
recognize. This structure consists at least partly of singlestranded DNA (ssDNA), which is also the trigger for the SOS DNA damage response in bacteria 13 . In bacteria, a ssDNA-binding protein, recombinase A (RecA), triggers the SOS response; similarly, the canonical ATR pathway is triggered by the binding of a ssDNA-binding protein complex, replication protein A (RPA), to ssDNA. RPAssDNA interactions serve as a platform for the recruitment of many proteins, including ATR-interacting protein (ATRIP) 14 , which facilitates the recruitment of ATR to stressed replication forks 15 (FIG. 1a) .
Although RPA-ssDNA is sufficient to recruit the ATR-ATRIP complex, it is not sufficient for ATR activ ation 16 . Kinase activation depends on some as yet undefined ATR conformational change that is mediated by the binding of an activator protein 17 (FIG. 1) . In budding yeast, there are three proteins that activate mitosis entry checkpoint 1 (Mec1; the homologue of ATR): the DNA repli cation regu lator Dpb11, DNA damage checkpoint 1 (Ddc1) and DNA replication ATP-dependent helicase/ nuclease 2 (Dna2) [18] [19] [20] [21] (FIG. 1b) . In vertebrates, two ATR activators have been identified: topoisomerase II Figure 1 | Components of ATR activation pathways. a | (Left) DNA polymerase stalling on the lagging strand generates a single-stranded DNA (ssDNA) gap that is bound by replication protein A (RPA), providing a platform for ataxia telangiectasia and Rad3-related (ATR) activation. The 5ʹ-ended ssDNA-double-stranded DNA (dsDNA) junction formed at the Okazaki fragment adjacent to this ssDNA serves as the loading point for the RAD9-RAD1-HUS1 (9-1-1) clamp complex, which is loaded onto the DNA by the RAD17-replication factor C subunits 2-5 (RFC2-5) clamp loader. (Right) The 9-1-1 complex, with assistance from RAD9-HUS1-RAD1-interacting nuclear orphan (RHINO) and the MRE11-RAD50-NBS1 (MRN) complex, recruits the ATR activator topoisomerase II binding protein (TOPBP1), thereby allowing stimulation of ATR and phosphorylation of specific downstream effectors, including checkpoint kinase 1 (CHK1). Ewing tumour-associated antigen 1 (ETAA1) bound to RPA activates ATR in a parallel pathway. b | In Saccharomyces cerevisiae, Dpb11, DNA damage checkpoint 1 (Ddc1) and DNA replication ATP-dependent helicase/nuclease 2 (Dna2) each have a disordered ATR-activating domain (AAD), which contains crucial hydrophobic amino acids that are needed for activation of mitosis entry checkpoint 1 (Mec1; the budding yeast ATR homologue). In humans, the ATR activator TOPBP1 is a homologue of Dpb11, whereas ETAA1 is not related to any yeast protein and, unlike the other activators, contains two motifs (RPA70N and RPA32C) that interact with two domains of RPA [23] [24] [25] . c | The kinase domain of ATR is followed by two motifs that are needed for ATR activation: the PIKK-regulatory domain (PRD) and the FAT-carboxy-terminal (FATC) domain, which may directly contact the AAD of TOPBP1 or ETAA1 (REF. 17 ). ATR-interacting protein (ATRIP) contains an amino-terminal RPA-interaction domain (RPA70N), a coiled-coil dimerization domain (CC), a motif that is needed for AAD interaction and ATR activation, and a carboxy-terminal region that interacts with ATR 17, [163] [164] [165] [166] . d | Model of ATR activation. ATR-ATRIP forms a dimer of dimers 167 . Binding of the AAD of TOPBP1 or ETAA1 probably induces a conformational change in ATR that reduces the K m for its substrates and thereby activates it 168 . BRCT, BRCA1 C terminus. 
Replisome
A multiprotein complex that unwinds double-stranded DNA and catalyses both leading and lagging strand DNA synthesis.
Nascent DNA
The newly synthesized strands of DNA during DNA replication.
binding protein 1 (TOPBP1), which is a Dpb11 orthologue and contacts both ATR and ATRIP through its ATR-activation domain (AAD) 22 (FIG. 1b) ; and Ewing tumour-associated antigen 1 (ETAA1), which is recruited to stressed replication forks through direct interactions with RPA [23] [24] [25] (FIG. 1a) . ETAA1 is a large protein that also contains an AAD [23] [24] [25] . However, it does not share any sequence homology with the other yeast or human ATR activators outside of a small motif in the AAD (FIG. 1b) . TOPBP1 may be the more important activator, as mutations in its AAD are lethal in mice 26 , whereas mutations in the ETAA1 AAD do not significantly alter the growth of U2OS or HEK293T cells 23 . However, TOPBP1 also has important functions during the initiation of DNA replication, and whether mutations in its AAD disrupt TOPBP1 function at replication origins has not been determined 27 . The ATR activators are thought to be recruited to the stalled replication fork independently of ATR 12 . TOPBP1 recruitment is dependent on the presence of a 5ʹ-ended ssDNA-double-stranded DNA (dsDNA) junction. This junction serves as the loading point for the RAD9-RAD1-HUS1 (9-1-1) checkpoint clamp complex, which is required for TOPBP1 recruitment and subsequent stimulation of ATR kinase activity 28, 29 (FIG. 1a) . The 9-1-1 clamp is structurally similar to the proliferating cell nuclear antigen (PCNA) sliding clamp and is loaded onto the DNA by the RAD17-replication factor C subunits 2-5 (RFC2-5) clamp loader [30] [31] [32] . An alternative clamp loader, chromosome transmission fidelity 18 (CTF18)-RFC2-5, interacts with DNA polymerase ε (Pol ε) 33 , which is the enzyme that synthesizes the leading strand at the replication fork. In budding yeast, this interaction is a key step in the activation of the downstream replication checkpoint response 34, 35 . How this alternative clamp loader activates the checkpoint, and whether this is important for checkpoint activation in human cells, is unknown. Recruitment of TOPBP1 to the 9-1-1 clamp is also partially dependent on the MRE11-RAD50-NBS1 (MRN) complex 36, 37 and on RAD9-RAD1-HUS1-interacting nuclear orphan (RHINO) 38, 39 , although the mechanisms by which these components help recruit TOPBP1 are unknown. After it is bound to the 9-1-1 clamp, TOPBP1 interacts with ATR-ATRIP to stimulate ATR activation (FIG. 1a,d) .
Little is known about why there is more than one ATR-activating protein, but current evidence suggests that ETAA1 and TOPBP1 function in parallel and distinct pathways of ATR activation 23, 24 . ETAA1 and TOPBP1 may direct ATR towards distinct substrates, respond to different replication stress inputs, or serve to amplify or increase the robustness of the stress response.
Pathway-activating DNA structures
Because ATR does not directly recognize the DNA lesion, one focus in the field has been to define the DNA structure (or structures) that ATR does recognize and how it is formed. ATR-activating ssDNA can be generated through uncoupling of the helicase and DNA polymerase enzymatic activities of the replisome, such that the helicase continues to unwind the DNA ahead of the stalled polymerase 40 . This is not necessarily a physical uncoupling of the helicase and polymerase, as the replisome probably stays intact, but instead could be a functional uncoupling of enzymatic activities that allows the generation of ssDNA (FIG. 2a) . If the lagging-strand polymerase stalls at a DNA lesion then the ssDNA that is generated may be no longer than an Okazaki fragment (100-200 nucleotides), as repriming events should allow the fork to simply bypass the lesion. However, the nascent strand gap that is left may be expanded by exonucleases to generate a larger ssDNA platform for ATR recruitment and activation. If the stalling event is on the leading strand template, more extensive ssDNA could be generated directly by uncoupling. In the Xenopus laevis egg extract in vitro repli cation system, extensive unwinding can occur, but this may not be the case in human cells. Electron microscopy analysis of ssDNA at individual stressed forks revealed that various genotoxic agents typically caused ssDNA stretches ranging from 70 to 500 bases [41] [42] [43] . It may be that the persistence of such a relatively small amount of ssDNA is what is required to activate ATR.
At least for TOPBP1-dependent activation, ssDNA is not sufficient to activate ATR 16 . The loading of the 9-1-1 complex requires a free 5ʹ-ended ssDNA-dsDNA junction, which is needed for ATR activation in X. laevis egg nuclear protein extracts when there is not a free 3ʹ DNA end for DNA extension 16 . A 5ʹ end junction with an RNA-DNA primer is naturally formed on the lagging strand when the polymerase stalls owing to the discontinu ous manner of DNA synthesis on this strand (FIG. 1a) . Likewise, primer synthesis on the leading strand could also generate the appropriate junction 44 ( FIG. 2a) . Thus, the uncoupling of helicase and polymerase activi ties accompanied by DNA primer synthesis may be sufficient for TOPBP1-dependent ATR activation.
This model for ATR activation at a stressed fork explains the response to several types of agents that stall the DNA polymerase, but what if the polymerase stalls without significant uncoupling of helicase and polymerase activities? For example, an inter-strand crosslink could block replication without generating significant amounts of ssDNA, because it stalls the helicase, which is positioned at the forefront of the replisome. In these cases, active fork remodelling and DNA processing, such as fork reversal followed by nascent strand resection, could contribute to generating the checkpoint-activating structure (FIG. 2b) .
Fork reversal is thought to be a common mech anism of fork protection and repair 45 , during which the nascent DNA strands anneal to one another. Equilibrium between fork reversal and fork progression may be established in response to most types of replication stress 41, 46 . If the nascent lagging strand is shorter than the leading strand then an appropriate 5-ended ssDNA-dsDNA junction would be formed to activate ATR. However, if the nascent lagging strand is longer than the leading strand, enzymatic processing by a nuclease is needed to activate ATR. Indeed, DNA2 may resect nascent DNA at a reversed fork in the 5ʹ-to-3ʹ direction to generate the 5ʹ-ended ssDNA-dsDNA junction (FIG. 2b) . Consistent with this activity creating a signal that activates ATR, DNA2 depletion impairs ATR signalling 47 . How much cells rely on fork reversal and resection, as opposed to helicase-polymerase uncoupling, to generate ssDNA probably depends on the type of damage or stress that impedes fork progression.
If fork reversal is a common mechanism in generating an ATR-activating signal, then deficiencies in fork reversal enzymes would be expected to cause ATRactivation defects. As yet, there is little evidence for this, possibly because the enzymes needed to catalyse fork reversal are still poorly defined. Many enzymes can catalyse fork regression in vitro, including DNA translocases like SMARCAL1 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1), ZRANB3 (zinc-finger RANbinding domain-containing 3) and HLTF (helicase-like transcription factor) 48, 49 , as well as helicases such as BLM (Bloom syndrome RecQ-like helicase), FANCM (Fanconi anaemia complementation group M), FANCJ and WRN (Werner syndrome ATP-dependent helicase) 45 . Some combination of these enzymes is likely to cooperate with the RAD51 recombinase to generate reversed forks in cells 45 . Of these enzymes, genetic depletion of only the helicases FANCM, FANCJ and WRN has been linked to reduced ATR signalling 47, [50] [51] [52] [53] [54] [55] [56] [57] .
Other nucleases, such as endonuclease/exonuclease/ phosphatase family domain-containing 1 (EEPD1), have also been implicated in generating ssDNA at replication forks for ATR activation 58 , and ATR-activating structures can be generated without DNA replication. For example, resection of a DSB 59, 60 , or deprotection of a telomere, can activate ATR 10 . Also, some repair-related Figure 2 | Generation of the ATR-activating structure at stressed replication forks. a | When the leading strand polymerase stalls, a 5ʹ-ended single-stranded DNA-double-stranded DNA (ssDNA-dsDNA) junction is not initially present. New primer synthesis ahead of the stalled leading-strand polymerase would create the ssDNA-dsDNA junction. DNA polymerase α (Pol α) and/or PrimPol (primase and DNA-directed polymerase; not shown) may catalyse primer synthesis ahead of the stalled polymerase. b | Fork remodelling may be necessary to generate the ataxia telangiectasia and Rad3-related (ATR)-activating structure when a DNA lesion, such as an inter-strand crosslink (ICL), stalls the fork entirely. In this situation, DNA translocases may reverse the fork. When the fork has been reversed, specialized helicases, such as Werner syndrome ATP-dependent helicase (WRN) or Fanconi anaemia complementation group J (FANCJ; not shown), can unwind the dsDNA of the reversed strands. Exonucleases, including DNA replication helicase/nuclease 2 (DNA2), can resect the DNA in the 5ʹ-3ʹ direction as it is unwound by the helicase, generating both the ssDNA and the 5ʹ-ended ssDNA-dsDNA junction required for ATR activation. 9-1-1, RAD9-RAD1-HUS1; ATRIP, ATR-interacting protein; MCM2-7, minichromosome maintenance 2-7 complex; RPA, replication protein A; TOBP1, topoisomerase II binding protein 1. DNA processing, such as that taking place during excision repair, may be sufficient to generate a transient ATR-activating DNA structure, especially if repair is not completed promptly 61 . Interestingly, recent work has uncovered mechanisms that can shield some activating structures from ATR. For example, proteomic analysis and electron microscopy imaging of centromeric α-satellite DNA revealed the presence of DNA loops surrounded by a matrix of proteins that prevent RPA loading and ATR signalling at centromeres 62 . This suppression is needed to facilitate the replication of these sequences. As half of the genome is made up of repetitive DNA sequences, it will be important to understand how and when the exclusion of ATR is beneficial to the replication and repair of α-satellite DNA and other repetitive DNA sequences.
Thresholds of activation
Conditional deletion of ATR 2 or kinase inactivation with inhibitors 63 causes cell lethality, suggesting ATR is active during each S phase. It is unknown whether this is due to the continuous presence of mild replication stress or whether the process of replication inherently activates ATR. After all, the ATR-activating structure forms on the lagging strand during normal DNA synthesis, albeit transiently. Indeed, Mec1 phosphorylates and regulates numerous proteins during normal DNA replication, although its major effector, Rad53 (the budding yeast functional homologue of checkpoint kinase 1 (CHK1)), and other stress-induced Mec1 substrates were notably not found to be phosphorylated in normal growth conditions 64 . It was suggested that this Mec1 activation occurs at the lagging strand of a moving replication fork, because it required the 9-1-1 clamp and the lagging strand factor Dna2. This is distinct from Mec1 activation induced by replication stress, which is primarily dependent on Dpb11 and not Dna2 (REF. 64 ). More robust activ ation of ATR may require longer persistence of the activating structure than would be possible during the rapid synthesis and processing happening on the lagging strand during normal replication elongation.
Similarly, in human cells, CHK1 is not strongly phosphorylated by ATR during normal DNA replication. Nevertheless, inhibition of ATR or CHK1 has effects on unperturbed cells, suggesting that ATR and CHK1 are active in normal conditions. Even in the absence of TOPBP1 or ETAA1, purified ATR and ATR-ATRIP complexes retain some kinase activity 14, 65 . This basal level of activity may be sufficient to cause some substrate phosphorylation, particularly if ATR is directed to the substrate.
It is also possible that different biological responses require different levels of ATR activity. For example, common fragile sites (CFSs), which are specific chromosomal regions that are highly sensitive to replication stress, require ATR to maintain their stability under conditions of mild replication stress and even during unperturbed replication 66 , yet the major checkpoint effectors of ATR are not detectably phosphorylated under these conditions 67 . Importantly, chromosomal fragility at CFSs is detected and measured as breaks or gaps in metaphase chromosomes. Thus, conditions that hinder replication at CFSs may not cause a detectable cell cycle arrest, but nevertheless require ATR activity to prevent chromosomal fragility. This suggests that transient activation of ATR exists at individual forks that are intrinsically challenged, such as those at CFSs, and that ATR activity is crucial for the function of these forks.
Amplification of ATR signalling
Although it seems likely that different biological responses require different levels of ATR activity, cells also possess mechanisms to amplify ATR activation at individual replication forks. One way cells amplify ATR activity is by increasing the number of ssDNA-dsDNA junctions at a fork through continued primer synthesis 68 . For example, when a lesion stalls the leading strand polymerase and generates ssDNA ahead of the polymerase, cells are able to reinitiate DNA synthesis ahead of the stalled polymerase to create multiple short primers interspersed with ssDNA gaps (FIG. 3a) . ATR activation is greater, as measured by CHK1 phosphorylation, when there are more primers ahead of the stalled polymerase 68 , perhaps because repriming creates multiple 5ʹ-ended ssDNA-dsDNA junctions, which can recruit multiple 9-1-1 checkpoint clamps and additional TOPBP1 to activate ATR (FIG. 3a) . Importantly, this mode of pathway amplification is not restricted to leading strand lesions, as continued primer synthesis also occurs on the lagging strand.
We can envision at least two ways to create these primers. First, the recently described primase and DNAdirected polymerase (PrimPol) can prime new synthesis ahead of ultraviolet-induced lesions and hydroxyureastalled forks [69] [70] [71] [72] , although it has yet to be demonstrated that this amplifies ATR activation. Second, these primers may result from the priming activity of Pol α, which is a component of the replisome that provides primase (priming) activity on the lagging strand and initiates replication on the leading strand 68, 73 . Some evidence suggests that Pol α stimulates loading of the 9-1-1 complex 73 , and this may occur through primer synthesis along the ssDNA to generate multiple ssDNA-dsDNA junctions (FIG. 3a) .
Another way to amplify ATR activation is through feed-forward signalling loops, which is a common mechanism for the amplification of signal transduction. For example, the E3 ubiquitin ligase pre-mRNAprocessing factor 19 (PRP19; also known as PRPF19) is recruited to stalled replication forks, where it binds RPA-coated ssDNA and ubiquitylates RPA 74 . RPA ubiquityl ation helps recruit ATRIP-ATR and promotes ATR activation. Importantly, ATR activation facilitates further PRP19 recruitment to RPA-coated ssDNA, forming a feed-forward loop for robust activation of the ATR pathway 74 (FIG. 3b) . Sumoylation of ATRIP may also prime the ATR pathway for activation and boost protein interactions among the upstream ATR activ ators 75 . Another feed-forward regulatory mechanism may involve the phosphorylation of ATR-activating proteins. Phosphorylation of TOPBP1 by ATM increases its ability to activate ATR 76 . Similarly, in budding yeast, Dpb11 is phosphorylated by Mec1, and this increases its ability to activate Mec1 in vitro 19 . ETAA1 is also phosphorylated in response to replication stress, although whether this affects ATR activation is not known 23, 24 . Post-translational modifications of ATR and ATRIP also contribute to ATR regulation (FIG. 3c) . ATRIP is both phosphorylated and acetylated [77] [78] [79] ; ATRIP phosphorylation by cyclin-dependent kinase 2 (CDK2) increases ATR signalling, whereas ATRIP acetylation decreases it. Deacetylation of ATRIP by sirtuin 2 (SIRT2) following replication stress increases the affinity of ATRIP for RPA 79 . ATR is also phosphorylated on multiple residues, including on Thr1989 (REFS 80, 81) , which may be autophosphorylated, although it is not part of the preferred consensus sequence recognized by ATR. Thr1989 phosphorylation may increase the ability of ATR to bind and be activated by TOPBP1 and to phosphorylate other substrates. Thus, ATR autophosphorylation could potentiate ATR activation, similar to a model proposed for ATM autophosphorylation 82 . However, the importance of both ATM and ATR autophosphorylation in signalling is controversial, as a mutation in the ATM autophosphoryl ation site did not impair ATM signalling in mouse models 83, 84 , and ATR signalling was not impaired in human cells expressing only the non-phosphorylatable ATR-T1989A mutant 81 . Other ATR phosphorylation sites, such as Ser428 and the nearby protein kinase A (PKA)-mediated phosphorylation site (Ser435), may be important regulators in specific stress conditions 85 .
Emerging themes in ATR pathway activation
Although we have a clear grasp of how the basic components function to activate ATR following replication stress, new and interesting themes have begun to emerge. Of interest is the role of the NIMA-related kinase (NEK) family in ATR activation. There are at least 11 members of the NEK family in humans, and many have reported roles in facilitating activation of the ATR pathway or downstream checkpoints 86 , raising the intriguing possibil ity that the NEK family evolved in part to modulate the ATR pathway.
The discovery of multiple ATR activators provides an additional way to regulate or amplify ATR signalling quantitatively. The persistent ssDNA generated by replication stress provides a platform for the recruitment of more ATR-ATRIP and ETAA1 to the stalled fork. As current evidence suggests that ETAA1 does not require the 9-1-1 complex to activate ATR, it is possible that it Nature Reviews | Molecular Cell Biology 
Origin firing
The initiation of DNA replication at an origin.
Fork restart
The process of restarting DNA replication at a fork that had been stalled.
amplifies ATR signalling even without the generation of additional 5ʹ-ended junctions (FIG. 3d) . What makes ATR more active when it is bound by an AAD is not known, but all the yeast and vertebrate ATR-activating proteins identified to date share a similar motif within their AAD that contains two large hydrophobic amino acids within a relatively unstructured region, which can interact with the ATR-ATRIP complex and promote its activation 87 . A mutation in ATR that prevents TOPBP1 binding and activation also impairs ETAA1 binding and activation 17, 23 . Furthermore, in vitro studies have shown that TOPBP1 and ETAA1 confer overlapping substrate specificity to activated ATR. These findings suggest that the mechanism of kinase activation of all ATR-activating proteins is similar, and that it may involve an allosteric change in ATR conformation that translates into a difference in the ability of ATR to bind substrates 17 . Thus, the abundance of ATR-activating protein in proximity to ATR could tune the amount of ATR signalling.
It is also possible that there are qualitative differences in the signalling of the ETAA1-ATR complex versus the TOPBP1-ATR complex. Unlike TOPBP1, ETAA1 may not need a 5ʹ-ended ssDNA-dsDNA junction to activate ATR, as it can bind directly to RPA (FIG. 3d) . Thus, it is possible that active ETAA1-ATR and TOPBP1-ATR complexes form on different DNA substrates and that their proximity to different substrates leads to differences in signalling. ETAA1 and TOPBP1 could also provide qualitative differences in signalling by directly binding to different ATR substrates. Much more work on these alternative ATR activators is needed to understand how having more than one is advantageous.
Finally, recent work has revealed a new mode of ATR activation at the nuclear envelope in response to mechani cal stress 11 . Although the molecular mechanism underlying ATR activation in this context is unclear, it does not require RPA, TOPBP1 or RAD17, strongly suggesting that this activation is not triggered by ssDNAdsDNA junctions 11 . However, given the mechanical forces associated with DNA replication and chromosome condensation, especially where chromatin is attached to the nuclear envelope, it is likely that ATR activation in response to mechanical stress contributes to the integrity of the genome. Continued work on this emerging aspect of ATR activation is needed before a clear model can be developed, but the activation of ATR following mechanical stress seems to indicate that there may be other mechanisms of ATR activation.
ATR functions during DNA replication When activated at stressed replication forks, ATR orchestrates a multifaceted response that protects the integrity of the genome. Instrumental to this response is the downstream effector, CHK1, which is a kinase that is activated by phosphorylation by ATR 12 . Together, ATR and CHK1 function to arrest the cell cycle, suppress origin firing, stabilize replication forks and promote fork repair and fork restart. By coupling cell cycle arrest to fork stabilization and restart, ATR and CHK1 probably ensure that cells do not enter mitosis when replication is perturbed.
Cell cycle arrest
One crucial function of the ATR pathway is to arrest the cell cycle following DNA damage in S phase. This arrest is initiated by the phosphorylation of CHK1 by ATR, a reaction mediated by Claspin, which helps to bring CHK1 to the replication fork and into proximity with ATR 88 . When activated, CHK1 phosphorylates and inactivates the CDC25 phosphatases, CDC25A, CDC25B and CDC25C 89 . These phosphatases remove inhibitory phosphorylations from CDK2 and CDK1, and are required to activate the cyclin-CDK complexes necessary for cell cycle progression 90 . The mechanisms of checkpoint-mediated CDC25 inactivation vary. CHK1-dependent phosphorylation of CDC25A triggers its rapid degradation in S phase 91, 92 . By contrast, CDC25C phosphorylation leads to its association with 14-3-3 signalling modifier proteins and sequestration into the cytoplasm 93, 94 . Although all three phosphatases are negatively regulated by the ATR-CHK1 pathway following DNA damage, evidence from a genome-wide CRISPR screen in haploid stem cells suggests that CDC25A is the most important target and a major determinant of sensitivity to ATR inhibition 63 .
Regulation of origin firing
Origin firing is tightly regulated and occurs in an orderly fashion, both in terms of the timing and the spacing of initiation events 95 . Depending on the cell type, replication origins within specific chromosome domains fire exclusively in early, mid or late S phase. ATR and CHK1 are negative regulators of origin firing and prevent excessive origin firing even during an unperturbed S phase. Early studies in X. laevis egg extracts indicate that loss of ATR leads to excessive origin firing, particularly in early S phase 96, 97 . Furthermore, loss of CHK1 activity in mammal ian cells results in late origin firing in early S phase, in part owing to premature activation of the cyclin A-CDK1 complex, which is thought to promote late origin firing 98 . This function of the ATR-CHK1 pathway may limit the density of active replication forks throughout the genome so that replication forks have a sufficient supply of DNA precursors and replication factors for optimal fork progression.
ATR also has a crucial role in limiting DNA replication by blocking initiation in response to replication stress [99] [100] [101] . ATR prevents origin firing by blocking the recruitment of CDC45 to the minichromosome maintenance 2-7 complex (MCM2-7), which is a heterohexameric helicase complex that unwinds DNA at the replication fork
. Helicase activation requires CDC45 binding, which occurs following CDK-dependent phosphorylation of Treslin (also known as TICRR; Sld3 in budding yeast) 102 and DBF4-dependent kinase (DDK)-mediated phosphorylation of the MCM2-7 complex 103 (FIG. 4a) .
Accordingly, one way the ATR-CHK1 pathway may prevent CDC45 loading and helicase activation is by downregulating the kinase activities of CDK and DDK. Indeed, in yeast, the CHK1 homologue Rad53 phosphoryl ates dumbbell forming 4 (Dbf4) to suppress DDK activity in response to replication stress 104, 105 , and human CHK1 phosphorylates CDC25A, thereby triggering its rapid degradation and CDK inhibition 91, 106 .
Another mechanism by which the intra-S phase checkpoint blocks CDC45 recruitment is through ATRdependent phosphorylation of the histone methyltransferase myeloid/lymphoid or mixed-lineage leukaemia (MLL; also known as KMT2A) 107 . This leads to MLL stabilization and its accumulation on chromatin, where it methylates histone H3 Lys4. This modification prevents loading of CDC45 at nearby replication origins, and thus suppresses origin firing (FIG. 4a) . In budding yeast, downstream of Mec1, Rad53 suppresses origin firing in response to DNA damage by phosphorylating Sld3 (REFS 105, 108) . This phosphorylation also blocks loading of Cdc45 at origins and thereby enforces the intra-S phase checkpoint. A similar pathway is found in humans, in which CHK1 phosphorylates Treslin, the functional homologue of Sld3, to block CDC45 loading and suppress origin firing 109 (FIG. 4a) .
A key aspect of the ATR-dependent checkpoint is that, under conditions of replication stress, it suppresses origin firing globally, yet allows dormant origin firing locally 110 (FIG. 4b) . The firing of dormant origins within an actively replicating region supports the completion of DNA replication within these regions. At the same time, the global suppression of new origin firing minimizes widespread DNA polymerase stalling and prevents problematic replication at later-replicating regions of the genome.
Within a chromatin domain, clusters of origins fire concurrently. Genetic disruption or chemical inhibition of the ATR-CHK1 pathway significantly decreases both the rate of fork progression and the inter-origin distance (IOD) at local origin clusters [111] [112] [113] [114] [115] [116] , suggesting that ATR and CHK1 modulate replication initiation events locally, perhaps through direct regulation of the CDC25-CDK pathway. However, this effect within local domains may be indirect, as dormant origins may fire passively if loss of ATR or CHK1 causes slower fork progression. Partial inhibition of CDK activity restores the IOD and the rate of fork progression in CHK1-inhibited cells 114 . CDK inhibition would prevent further origin firing and reduce the number of active forks. This, in turn, would be predicted to increase the pool of available dNTPs and, correspondingly, increase the rate of fork progression. Indeed, addition of dNTP precursors increases both the fork progression rate and the IOD in CHK1-inhibited cells 116 . Therefore, the decreased IOD in CHK1-inhibited cells may be a consequence of slower fork progression. Importantly, nucleoside addition did not increase the distances between initiation events in ATR-inhibited cells, suggesting that ATR modulates the IOD in a manner distinct from that of CHK1.
That the checkpoint can simultaneously suppress global origin firing, yet allow local dormant origin firing is clearly advantageous to cells; however, how local dormant origins escape checkpoint inhibition remains enigmatic 102 . One possibility is that CDC45 is already loaded at dormant origins within actively replicating regions. If so, these origins would be beyond the activ ation step controlled by the checkpoint. Indeed, in X. laevis egg extracts, modulating CDK activity does not seem to induce dormant origin firing within actively replicating regions 117 . ATR may also block the checkpoint inhibition of nearby dormant origins by phosphorylating MCM2 (REF. 118 ). In X. laevis egg extracts, Mcm2 phosphorylation recruits Polo-like kinase 1 (Plk1), which inhibits Chk1 activity. This could allow origins near a stalled fork, where ATR is active, to fire 119 (FIG. 4c) . Finally, recent data suggest that ATR regulation of global and local origin firing is even more complex, in that it depends on the level of replication stress. In mild-to-moderate levels of replication stress, FANCI binds to unfired origins and directs DDK-dependent phosphorylation of the MCM2-7 helicase and subsequent dormant origin firing 120 . However, when replication stress is high, ATR phosphorylates FANCI and blocks FANCI-mediated dormant origin firing. Clearly, the regulation of origin initiation is complex and further studies are needed to assemble all the regulatory mechanisms into a unified model.
Maintaining replication fork stability
It is well established that ATR is essential for stabilizing stressed replication forks 67, [121] [122] [123] (FIG. 5) . Replication fork stabilization is loosely defined as maintaining the ability of stalled polymerases to restart DNA synthesis following removal or bypass of a block to replication elongation. An unstable fork cannot resume DNA replication and is said to have collapsed, a process that at the molecular level often involves the formation of a DSB at
Box 1 | Origin firing
Initiation of DNA replication at origins is a two-step process: origin licensing and origin firing 95 . Both steps are strictly regulated and occur during separate phases of the cell cycle. First, origins are licensed in late mitosis and early G1 by loading on chromatin the pre-replicative complex (pre-RC), which includes, among other factors, the origin recognition complex (ORC) and the core replicative helicase complex minichromosome maintenance 2-7 (MCM2-7; see the figure). MCM2-7 helicase activation follows when origins fire in S phase. Helicase activation requires the loading of the preinitiation complex (pre-IC), which includes Treslin, cell division cycle 45 (CDC45), the GINS complex (SLD5-partner of SLD five 1 (PSF1)-PSF2-PSF3), topoisomerase II binding protein 1 (TOPBP1), a DNA polymerase and other replication factors (see the figure) . Recruitment of the pre-IC is dependent on the activities of the DBF4-dependent kinase (DDK) and the S phase cyclin-dependent kinase (CDK). The two kinases phosphorylate several factors needed to recruit the pre-IC and to activate MCM2-7 to unwind the DNA and initiate replication.
Throughout the genome, clusters of replication origins fire simultaneously, and the space between these origins is typically 50-150 kb. Some clusters fire earlier in S phase than others. Although an average of 4-6 origins actually fire in a typical cluster, the number of licensed origins within a cluster is thought to be approximately 20-fold higher 95 . Some of these unused origins are referred to as dormant origins and are used only if the replication forks emanating from fired origins are stalled or slowed 162 . Accordingly, dormant origins are often thought of as back-up origins that facilitate the completion of DNA synthesis within a cluster when the progression of neighbouring replication forks is impeded. (FIG. 5a) . Precisely how this occurs has been a matter of debate. Initially, it was proposed that fork collapse involved dissociation of the replisome, a conclusion based primarily on the study of a few replication forks in budding yeast 124 ; however, recent large-scale genomic data in budding yeast and proteomic experiments in human cells indicate that the replisome itself is stable in ATR-deficient cells 125, 126 . Instead, fork collapse may be an active process driven by structure-specific nucleolytic enzymes that catalyse the cleavage of structured DNA formed at stalled or remodelled replication forks. DSBs may also be an intermediate generated in a process of recombination-based replication restart.
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Inhibition of nuclease-dependent fork collapse. ATR function is required to prevent the nuclease-mediated cleavage of replication forks. However, as yet, there is little evidence that ATR directly regulates structurespecific nucleases; instead, fork cleavage may result from the failure of ATR to regulate fork processing events, such as fork reversal. Indeed, in budding yeast, Rad53 restrains fork reversal and prevents nucleolytic processing of stressed replication forks 43, 127 . Moreover, in human cells, the putative fork reversal enzyme SMARCAL1 is phosphorylated by ATR, thereby decreasing its ability to reverse forks in vitro and suppressing fork collapse in cells 115 (FIG. 5b) . Loss of this regulation by ATR may lead to excessive fork reversal in cells and, subsequently, to DNA cleavage. In fact, loss of structure-specific endonuclease subunit SLX4, which is a scaffold protein that binds to several structure-specific nucleases, reduces the formation of DSBs in ATR-inhibited cells, suggesting that an SLX4-dependent nuclease may process the four-way junction of the reversed replication fork 115, 128 (FIG. 5b) .
The effects of ATR loss on fork stability may also be indirectly tied to its effects on CDK activity and cell cycle progression. Some of the structure-specific endonuclease complexes are CDK-regulated and become activated in Figure 4 | Pathways regulated by ATR to suppress origin firing. a | (Left) DBF4-dependent kinase (DDK) and cyclin-dependent kinase (CDK) activities promote origin firing. DDK phosphorylates the minichromosome maintenance 2-7 complex (MCM2-7) helicase, and CDK phosphorylates Treslin. These phosphorylations promote recruitment of cell division cycle 45 (CDC45) and other pre-initiation complex (pre-IC) factors to activate the helicase. (Right) Ataxia telangiectasia and Rad3-related (ATR) may suppress origin firing through at least two distinct pathways. The first is through phosphorylation and stabilization of myeloid/lymphoid or mixed-lineage leukaemia (MLL). This promotes MLL association with chromatin, where it methylates histone H3 Lys4 (H3K4me). This chromatin modification blocks CDC45 loading onto nearby origins. The second pathway is through ATR-dependent activation of checkpoint kinase 1 (CHK1), which negatively regulates CDK-dependent phosphorylations at origins, thereby blocking the loading of CDC45 and other pre-IC factors. CHK1 also directly phosphorylates Treslin, which limits CDC45 binding to origins. b-c | ATR allows local dormant origins to fire in response to replication stress. b | When a replication fork is stalled, nearby dormant origins fire to help complete DNA synthesis in their vicinity. At the same time, cells block origin firing in later-replicating regions. This prevents the accumulation of additional replication stress and the potential depletion of replication factors or nucleotides. c | It is unclear how ATR allows dormant origins to fire locally. One proposed mechanism involves inhibition of CHK1 activity in the vicinity of the stalled polymerase. ATR activated at the stalled fork can phosphorylate MCM2 locally, primarily at nearby unfired origins. MCM2 phosphorylation creates a docking site for Polo-like kinase 1 (PLK1), which suppresses activation of CHK1 and allows recruitment of CDC45 to nearby origins. ORC, origin recognition complex.
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Holliday junctions
Branched structures that contain a four-way junction of double-stranded DNA.
late G2 phase or mitosis to resolve Holliday junctions and under-replicated loci 129 . This is an important process in mitosis, as it is necessary for the separation of sister chromatids during anaphase. However, if these nucleases are activated prematurely in S phase owing to increased CDK activity, they could process stalled replication forks into DSBs. This is observed when the G2-M checkpoint kinase WEE1 is inhibited in S phase 130, 131 and may also be the case in ATR-deficient cells. Some structure-specific nucleases, such as the EME2-MUS81 endonuclease complex, are active in S phase and promote restart of stalled replication forks 132 . Thus, nuclease-dependent DSB formation in ATR-inhibited cells may be an attempt to restart inactivated replication forks.
Downstream of ATR, CHK1 also stabilizes stressed replication forks. CHK1 inhibition leads to endonuclease-dependent fork collapse, which is catalysed by MUS81 (REFS 116, 133, 134) . In vitro, MUS81 can cleave stalled replication forks, and in the absence of MUS81 many fork-associated breaks do not form 135 . However, MUS81 is not essential for fork collapse in ATR-inhibited cells 115, 128 . Furthermore, CHK1 inhibition alone causes massive fork collapse in S phase cells and cell death, whereas ATR inhibition alone does not. This could reflect redundancy with the other DNA damage response kinases, including DNA-PK and ATM, which may phosphorylate and partially activate CHK1 in ATR-deficient cells 136 . However, CHK1 could also have essential activity in the absence of these upstream kinases, and basal CHK1 activity could be vital for the stabilization of replication forks.
Control of replisome function. Although the replisome may remain stable when ATR is inhibited, other aspects of its function may be regulated by ATR. Indeed, ATR phosphorylates many replisome components following replication stress, including several DNA polymerases, the clamp loader RFC1-5, MCM2-7, RPA and the ClaspinTimeless-TIPIN-AND1 complex 12, 137 . Consistent with this idea, in budding yeast Mec1 phosphorylates several components of the replicative helicase, including the DNA replication protein partner of Sld five 1 (Psf1), to alter 
DNA damage tolerance
A set of pathways that allow cells to replicate damaged DNA, including translesion synthesis and template switching.
Template switching
The transferring of the DNA polymerase to using the newly synthesized DNA strand as a template for DNA replication when the parental template is damaged.
replisome progression 125 . Moreover, in human cells, ATR recruits FANCD2 to the replication fork. FANCD2 recruitment may be mediated by binding of MCM2-7, and correlates with MCM2-7 phosphorylation by ATR 138 (FIG. 5c) . FANCD2 slows the progression of the DNA polymerase, and presumably the helicase; importantly, it also minimizes ssDNA formation and meiotic recombination 11 homologue A (MRE11)-dependent resection of DNA at stressed forks 138 . It is unknown whether the slowing of fork progression is ATR-dependent. DNA lesions themselves slow polymerase progression, but in budding yeast this effect was found to be independent of Mec1 and Rad53 (REF. 122 ). The CHK1 homologue in fission yeast, Cds1, was suggested to slow fork movement in response to DNA damage 139 . Similarly, in human cells, CHK1 was shown to slow fork elongation rates following camptothecin-induced DNA damage 140, 141 . Although the precise mechanisms have yet to be identified, these results suggest that ATR modifies the function of the replisome to prevent unwanted DNA resection or unwinding at the fork, and perhaps to slow replication elongation (FIG. 5c) .
Exhaustion of replication factors. ATR may also stabilize replication forks indirectly, by suppressing late-origin firing and preventing the depletion, or 'exhaustion' , of RPA. RPA exhaustion is observed when ATR inhib ition is combined with replication inhibition by hydroxy urea or aphidicolin 142 . Under these replication stress conditions, the accumulation of ssDNA at replication forks as a result of excessive origin firing, helicase-polymerase uncoupling and DNA-end resection seemingly exceeds the availability of RPA 142 . RPA is needed to regulate the recruitment and activities of DNA repair and fork reversal enzymes; therefore, its exhaustion leads to widespread fork collapse (FIG. 5d) .
The suppression of origin firing in ATR-inhibited cells delays RPA exhaustion, suggesting that the pool of available RPA is initially sufficient to coat and protect the ssDNA formed at active replication forks. Accordingly, RPA exhaustion may be particularly detrimental to repli cation forks emanating from the aberrantly fired origins in ATR-inhibited cells. Indeed, non-homologous end-joining repair proteins accumulate at aberrantly fired origins in ATR-inhibited cells, instead of the normal homologous recombination factors that promote fork restart 126 . Intriguingly, suppressing new origin firing also results in the retention of homologous recombination factors, including RAD51 and breast cancer type 1 susceptibil ity (BRCA1), at stressed forks. This may suggest that, like RPA, homologous recombination factors could become exhausted when ATR inhibition is combined with replication stress. However, as ATR phosphorylates RPA 143, 144 and the homologous recombination factors partner and localizer of BRCA2 (PALB2) 145, 146 and X-ray repair cross-complementing 3 (XRCC3) 147 , it is also possible that homologous recombination factors in ATR-inhibited cells are not properly activated. As fork restart can involve a RAD51 recombination-dependent process 148 , a functional loss of homologous recombination may also contribute to the fork instability seen in ATR-deficient cells.
Regulation of replication fork restart
Another aspect of ATR-mediated fork stabilization involves the regulation of pathways that actively promote replication fork restart, in addition to those that prevent fork collapse (FIG. 6) . Multiple processes have been suggested to promote fork restart 1 . For example, fork restart may involve repriming by PrimPol ahead of the stalled polymerase. Other processes that promote fork restart involve the DNA damage tolerance pathways, which facilitate continued DNA synthesis without repairing the lesion. This can occur through direct bypass of damage, a process that involves translesion polymerases. Alternatively, template switching may occur, allowing the use of the undamaged sister chromatid as a template for replication. Replication restart may also occur through fork reversal processes 45 . Fork reversal can place a polymerase-blocking lesion back into the context of dsDNA so that repair can occur. Replication can then continue after the reversed fork is reset. Finally, endonucleases may also cleave a reversed or stalled fork to facilitate homologous recombinationmediated mechanisms of fork restart 149 (FIG. 6) .
How precisely ATR functions in these processes is not clear, but it probably contributes to several of them. ATR phosphorylates two of the translesion polymerases, reversion less 1 (REV1) and Pol η 150, 151 , suggesting that ATR may control lesion bypass. Other fork restart pathways, including template switching, fork reversal and homo logous recombination, require RAD51 (REFS 45, 149) . Importantly, ATR probably regulates RAD51-dependent fork restart pathways, as several factors that act in these pathways are ATR substrates and are required for ATRmediated fork restart. For example, ATR phosphorylates RPA, PALB2 and XRCC3, and these modifications are thought to promote RAD51 recruitment to stalled forks or DSBs at collapsed forks [143] [144] [145] [146] [147] . ATR also phosphorylates the helicases BLM and WRN, which may promote repli cation restart by processing repair intermediates 152, 153 (FIG. 6) . However, until we have good methods to distinguish between the effects of ATR on fork stabilization and on fork restart, it will be difficult to clearly delineate the molecular mechanisms and processes that occur when forks stall and restart.
Ensuring dNTP availability
In addition to maintaining the stability of stalled forks, ATR actively prevents forks from stalling in the first place by ensuring that dNTP levels in replicating cells are sufficient. Early genetic studies in budding yeast demonstrated that the lethality caused by Mec1 loss could be rescued by increasing the activity of ribonucleotide reductase (Rnr), which is the rate-limiting enzyme in dNTP production 154, 155 . By overexpressing Rnr or deleting an Rnr inhibitor, nucleotide levels are increased in the Mec1-deficient yeast, thereby yielding fewer stalling forks and reducing the need for replication stress signalling. Furthermore, Mec1 regulates Rnr activity in yeast by multiple mechanisms 156 . Similarly, in human cells, ATR activity is needed for efficient transcription factor E2F1-dependent expression of ribonucleoside-diphosphate reductase subunit M2 (RRM2) 136 . ATR-mediated RRM2 expression may be especially important in the early stages of S phase, when loss of ATR leads to the formation of greater levels of ssDNA. ATR also boosts RNR activity when DNA damage levels (and consequently the need for dNTPs) are high by preventing CDK-and cyclin F-dependent RRM2 degradation 157 . The importance of ATR in maintaining RRM2 expression and, consequently, dNTP levels was recently explored in a mouse model of Seckel syndrome 158 . Seckel mice have an Atr mutation that leads to reduced levels of ATR, similar to what is observed in humans with ATR mutations. These mice recapitulate many of the ATR mutation pheno types seen in humans, including craniofacial abnormalities and dwarfism 159 . Strikingly, crossing the Seckel mouse with mice genetically engineered to express supra-physiological levels of RRM2 resulted in a consider able increase in the overall size and lifespan of the mice. This elegant genetic study strongly supports the importance of ATR in regulation of dNTP biosynthesis 158 .
Conclusions and future directions
The past few years have revealed complexities in ATR regu lation and function that emphasize its essential roles in maintaining genome integrity. The use of new reagents, such as highly potent ATR inhibitors, has led to new discoveries, and such reagents are being developed for cancer therapies 160 . Cancer cells have elevated levels of replication stress and may be more dependent than normal cells on ATR function. ATR inhibition also sensitizes cells to many current agents that target DNA repair and replication. Thus, combining ATR inhibition with therapies that induce replication stress, or targeting cancers with high levels of replication stress, may be useful clinical strategies. Finding the individuals who will benefit from these drugs and identifying biomarkers that predict drug responses remain essential areas of investigation.
The identification of the second ATR activator, ETAA1 , illustrates that much is left to learn about the basic mechanisms of ATR regulation. Unanswered questions include: why do cells need multiple ATR activ ators? How is ATR signalling tuned to yield different cellular responses? What is the complete collection of ATR targets that is needed to execute an effective replication stress response?
New approaches, such as high-resolution cryo-electron microscopy, will hopefully reveal how ATR is activated at atomic resolution. A high-resolution structure may explain how post-translational modifications and other processes generate different levels of ATR signalling. The recent biochemical reconstitution of origin-dependent DNA replication 161 also provides an opportunity to build fully defined in vitro systems to study replication stress responses.
The genome cannot be fully protected from exogenous and endogenous sources of damage that threaten its stability. Fortunately, ATR solves many of the genome maintenance challenges to ensure the integrity of the information stored in the DNA. In addition to stabilizing the replication fork, ataxia telangiectasia and Rad3-related (ATR) is thought to promote restart of stalled forks. There are several pathways to restart a stalled fork, including repriming ahead of the lesion by primase and DNA-directed polymerase (PrimPol), lesion bypass through translesion synthesis (TLS), lesion bypass through template switching, and fork reversal and lesion repair. If a stalled fork collapses into a DNA double-strand break (DSB), homologous recombination-dependent pathways can restart the fork. It is unknown whether ATR regulates PrimPol activity to restart replication forks, but ATR does phosphorylate two TLS polymerases, reversionless 1 (REV1) and DNA polymerase η (Pol η), and may promote lesion bypass. ATR also phosphorylates several proteins that promote RAD51-dependent replication restart pathways, including template switching, fork reversal and repair, and homologous recombination. These include X-ray repair cross-complementing 3 (XRCC3), partner and localizer of BRCA2 (PALB2), replication protein A (RPA), Werner syndrome ATP-dependent helicase (WRN) and Bloom syndrome RecQ-like helicase (BLM).
